Skip to Content

Kaya Holdings Inc KAYS Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 0.05
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range 0.05  –  0.05
  • Year Range 0.04  –  0.10
  • Market Cap 997,777.5750
  • Volume / Avg 680.0 /  9,227.1
  • Price / Sales 2.09
  • Price / Book
  • Forward Div Yield 2.51%
  • Trailing Div Yield

Morningstar‘s Stock Analysis KAYS

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics KAYS

Company Profile KAYS

Business Description

Kaya Holdings Inc is a holding company. It pursues medical and recreational licenses for the growing, processing, and sale of marijuana in jurisdictions through its subsidiaries. The company owns and operates brands that produce, distribute, and sell premium cannabis products including flowers, concentrates, and cannabis-infused baked goods and candies. It mainly operates a vertically integrated seed-to-sale legal marijuana enterprise and its operations include medical marijuana dispensaries, medical marijuana grow-operations, the manufacturing of proprietary cannabis products, and research and development of medical-grade cannabis strains and extracts for pain relief and treatment of serious illnesses. The company operates the Kaya Shack brand of medical marijuana dispensaries.

915 Middle River Drive, Suite 316
Fort Lauderdale, FL, 33304
Industry Drug Manufacturers - Specialty & Generic
Employees 19

Competitors & Peers KAYS

Morningstar does not cover competitors or peers for this firm.

FAQs for Kaya Holdings Inc Stock

No. KAYS does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

KAYS’s market cap is 997,777.58.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

KAYS’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare KAYS’s historical performance against its industry peers and the overall market.